\documentclass[final,20pt]{beamer}
\usepackage[T1]{fontenc}
\usepackage{lmodern}
\usepackage[orientation=portrait,size=a0,scale=1.15]{beamerposter} % Set the paper size to A0
%width=84.1,height=118.9
\usetheme{Frankfurt}
%\usetheme{gemini}
%\usecolortheme{nott}
%\setbeamercolor{structure}{bg=black, fg=blue!30!black}
%\beamertemplateshadingbackground{purple!0}{white}
\setbeamercolor{titlelike}{parent=structure,bg=blue!20}
\setbeamercolor{block title}{bg=blue!20,fg=black}
\setbeamercolor{maketitle}{parent=structure,bg=cyan}
%\setbeamercolor{background canvas}{bg=white}
\setbeamercolor*{block body}{bg=white,fg=black}
\usepackage{graphicx}
\usepackage{booktabs}
\usepackage{tikz}
\usepackage{pgfplots}
\pgfplotsset{compat=1.14}
\usepackage{anyfontsize}
\usepackage{etoolbox}
%\usepackage{titlesec}
%\titlespacing{\title}{0pt}{\parskip}{-\parskip}
\usepackage{mwe}
\usepackage{graphicx}
\usepackage{hyperref}
\usepackage{natbib}
\usepackage{apalike}
\usepackage{caption}
\usepackage{subcaption}



\newlength{\sepwidth}
\newlength{\colwidth}
\setlength{\sepwidth}{0.025\paperwidth}
\setlength{\colwidth}{0.45\paperwidth}
\newcommand{\separatorcolumn}{\begin{column}{\sepwidth}\end{column}}
% ====================
% Title
% ====================
\title {\textbf {BAYESIAN NON-PARAMETRIC MIXTURE MODEL FOR  SURROGATE MARKER}}
\author {\textbf {MERCY KALONDU PETER}}
\date{}
	

% ====================
% Footer (optional)
% ====================


% ====================
% Body
% ====================
%\addtobeamertemplate{frametitle}{\vspace*{-1.4cm}}{\vspace*{0.2cm}}
\begin{document}
\begin{frame}[t]
	\vspace{-5pt}             %removes margin between headline and colorbox
	\begin{beamercolorbox}{}
		\maketitle
	\end{beamercolorbox}
	\vskip 0mm
\begin{columns}[t] % Set up columns
\begin{column}{.3\linewidth} % Set the width of this column
\begin{block}{\textbf {Mixture Model} }
	
		In mixture model, data is generated by first sampling the latent variables followed by the observables from a distribution which depends on the latent variables.
		\begin{equation}
		p(z,x)= p(z)p(x|z).
		\end{equation}
		where, $z$ is a latent variable, $x$ are the observed variables, $p (z) $ is a multi-modal distribution and $p (x|z) $ is a distribution of the observables given the latent variables and takes a variety of parametric forms.
	
\end{block}
\begin{block}{\textbf {Non-parametric mixture method}}
	It allows for probabilistic allocations of different points of the data to various groups  with the help of probabilistic tools like the Dirichlet process.
	Under Bayesian approach the main interest is on the posterior distribution , which is the conditional distribution of the parameter $\theta$ given the data in \ref{eqn 1.6}.
	\begin{eqnarray} 
	Q[\theta \in \cdot |X_{1}= x_{1},...,X_{n} =x_{n}] .\label{eqn 1.6}
	\end{eqnarray}
	Bayesian non-parametric mixtures use several distributions comprising of countably infinite number of parameters.
	\begin{eqnarray}
	G= \sum_{i=1}^{\infty}\pi_{i}\delta_{\theta_{i}} .
	\end{eqnarray}
	where G is the random mixing distribution, $\pi_{i}$ and $\theta_{i}$ are random sequences and $\delta_{\theta_{i}}$ are the Dirac measures (atoms of $\theta$) .	
	\end{block}

\begin{block}{\textbf {Biomarkers}}
	
A biological marker (biomarker) is a measurable feature or characteristic that shows the extent or the existence of a disease state \citep{gosho2012study}.
	
	\begin{itemize}
		\item \textbf{Predictive Biomarkers} predict the differential outcome of a particular treatment. Categorizes patients by their degree of response to a particular treatment.
		\item \textbf{Prognostic Biomarker} identity's patients with differing risks of a specific outcome, that is either progression of a disease or death.
		\item \textbf{Pharmacodynamic  biomarkers} indicate the drug effect on the target in an organism.
		\item \textbf{Surrogate endpoints} are used to minimize the duration and size used in clinical trials by indicating the effect of the treatment earlier before the clinical outcome.
	\end{itemize}		
\end{block}

\begin{block}{\textbf {General Model}}

$T$ =  treatment effect\\ 
$X$ =  baseline biomarker \\
$Y$ =  post treatment values\\
$E$ = clinical outcome \\
$Z$ = covariates present\\
For $p(.)$  a distribution,e.g. $P(E|X,Y,Z,T)$ a conditional distribution of the clinical outcome dependent on the  biomarker baseline value, post treatment value, treatment and the covariates.\\
Due to the treatment effects there will be within patient effects from  $X$ to  $Y$.\\
To assess the change, the relationship between  $X$ and $Y$ is considered, thus, the distributions  $P(X|Z)$ and $P(Y|X,Z,T)$.

\end{block}

\begin{block}{\textbf {Biomarker Functional Profile}}
	
	$\Delta$ = $\Delta ( p(X,Y|Z,T))$
	Through probabilistic factorization the general model is;
	\begin{eqnarray}
	p (E,X,Y|Z,T) = p(E|X,Y,Z,T) p(X,Y|Z,T).  \label{four}
	\end{eqnarray}
	From \ref{four}, the following assumptions are considered;
	\begin{enumerate}
		\begin{item}[i.]
			$p(E|X,Y,Z,T)= p(E|\Delta,Z,T)$, which implies,  with the effect of the covariates and the treatment, the impact of the $(X,Y)$ on  $E$ is indicated by the change. 
		\end{item}
		\begin{item}[ii.]
			The distribution of $X$ and $Y$  do not depend on the covariates. 
		\end{item}
	\end{enumerate}
	$p(X,Y|T)$ employs a hierarchical Bayesian non-parametric,and $p(E| \Delta,Z,T)$ employs a Bayesian non-parametric regression model to give adaptable cluster estimates for individuals specific distributions of $\Delta$ and  their clusters.\\
	
\end{block}
\begin{block}{\textbf {Distributional Change}}
	
	Subjects are indexed by $i = 1,...,N$,
	
	For the $i^{th}$ individual let $n_{i}$ and $m_{i}$ be the frequencies of measurements of the biomarker levels obtained before and after the treatment. Let $X_{i}$ = ($X_{i1}$,...,$X_{in_{i}}$) and $Y_{i}$ = ($Y_{i1}$,...,$Y_{imi}$) be the subject specific pre and post-treatment biomarker samples, where, X = ($X_{1}$, $X_{2}$,...,$X_{N}$) and Y = ($Y_{1}$, $Y_{2}$,...,$Y_{N}$)
	vertical quantile function is;
	\begin{eqnarray}
	Q_{X,Y}(p)= F_{Y }\left( F_{X}^{-1}(p)\right) \hspace*{0.3cm}\text{for p} \hspace*{0.3cm} \in (0,1).\label{4}
	\end{eqnarray}
	Thus, the measure of the distributional change is;
	
	\begin{eqnarray}
	\Delta = \int_{0}^{1} Q_{X,Y}(p)dp = E_{F_{Y}}(F_{X}(Y)) = p(X\textless Y).\label{five}
	\end{eqnarray}	
\end{block}
\end{column}

\begin{column}{.3\linewidth} % Set the width of this column


\begin{block}{\textbf {Bayesian Non-Parametric Mixture Model}}
	The Biomarker measurements are samples from unknown subject specific distributions with $X_{i1},...,X_{in_{i}}$ $\stackrel{ind}{\sim}$ $F_{X_{i}}$ and $Y_{i1},...,Y_{im_{i}}$ $\stackrel{ind}{\sim}$ $F_{Y_{i}}$ , Where $X_{i}$ and $Y_{i}$ are vectors of subject specific measurements.Both $F_{X_{i}}'s$ and $F_{Y_{i}}'s$  are modelled using mixtures of Gaussian distribution.
	For a DP with mass parameter $\alpha$ and a base measure $G_{0}$. Where $G_{0}$ is a base measure and $\alpha$ is a concentration parameter. Assuming that for each individual i= 1,...,N it follows that ;
	\begin{align}
	\begin{split}
	Y_{ik}|\mu_{Yik},\sigma_{Yik}\stackrel{ind}{\sim}N(\mu_{Yik},\sigma_{Yik}), \hspace*{0.5 cm} K= 1,.....m_{i}\\
	X_{ij}|\mu_{Xij},\sigma_{Xij}\stackrel{ind}{\sim} \prod_{j=1}^{p}N(\mu_{ij},\sigma_{Xij}),\hspace*{0.5 cm} j= 1,.....n_{i}\\
	(\mu_{Yik},\sigma_{Yik},\mu_{Xij},\sigma_{Xij}|G\stackrel{iid}{\sim} G,\\ 
	G \sim DP(\alpha, G_{0}). \label{eqn 4.22}
	\end{split}
	\end{align}
	where,\\
	$\alpha$= 1 , and  $G_{0}$ = N($\mu$,$\sigma$)\\For  $\theta_{Xij}$ = ($\mu_{Xij}$,$\sigma_{Xij}$) and $\theta_{Yij}$ = ($\mu_{Yij}$,$\sigma_{Yij}$). Under the mixture model  $\theta_{Xij}$ and $\theta_{Yij}$ are sampled from some mixing distributions $G_{Xi}$ and $G_{Yi}$ as follows;
	\begin{align}
	\begin{split}
	\theta_{Xi1},...,\theta_{Xin_{i}}|G_{X_{i}}\stackrel{ind}{\sim} G_{X_{i}}\\
	\theta_{Yi1},...,\theta_{Yim_{i}}|G_{Y_{i}}\stackrel{ind}{\sim} G_{Y_{i}} \label{3.5}
	\end{split}
	\end{align}
	Conditionals on the realizations of $G_{xi}$ and $G_{Yi}$, the distributions of the individual vectors $X_{i}$ and $Y_{i}$ are the following mixtures;
	\begin{align}
	\begin{split}
	f_{X}(x_{i}|G_{X_{i}})= \int \prod_{j=1}^{n_{i}}\phi(x_{ij};\theta_{X_{ij}})G_{X_{i}}(d\theta_{X_{ij}})\\
	f_{Y}(y_{i}|G_{Y_{i}})= \int \prod_{j=1}^{m_{i}}\phi(y_{ik};\theta_{Y_{ik}})G_{Y_{i}}(d\theta_{Y_{ik}}) \label{3.6}
	\end{split}	
	\end{align}
	
\end{block}
\begin{block}{\textbf {Prior Model}}
	A prior model is defined on $G_{X_{i}}$ and $G_{Y_{i}}$ and is a Dirichlet process.\\
	With $G_{Xi}$ and $G_{Yi}$  conditionally independent samples from a common DP prior, that is; 
	\begin{align}
	\begin{split}
	G_{Xi} \sim \sum_{k=1}^{\infty} \pi_{k}\sigma_{_{G_{0k}}} \hspace*{0.3cm} \text{and} \hspace*{0.3cm} G_{Yi} \sim \sum_{k=1}^{\infty} \pi_{k}\sigma_{_{G_{0k}}} \label{3.8}
	\end{split}
	\end{align}
	Where $G_{0k}$ is a realization from a common Dp prior that is DP($\gamma$,$G^{*}_{0}$) hyperprior 
	\begin{eqnarray}
	G_{0k}(\cdot) = \sum_{p=1}^{\infty} w^{*}_{pok}\delta_{\theta^{*}_{pok}}(\cdot)
	\end{eqnarray}
\end{block}
\begin{block}{\textbf {Hierarchical Model}}
	
	formulated using the nested Dirichlet Process(nDP) which is as follows;
	\begin{eqnarray}
	(G_{X_{i}}, G_{Y_{i}}) \sim nDP(\alpha,\gamma,G^{*}_{0})
	\end{eqnarray}
	Where  $G^{*}_{0}$ is a base measure which follows Normal-Inverse Gamma (N-IG) prior distribution, $\alpha$ and $\gamma$  are assigned  independent Gamma priors.
	
	\begin{align}
	\begin{split}
	Y_{ik}|\mu_{Yik},\sigma_{Yik}\stackrel{ind}{\sim}N(\mu_{Yik},\sigma_{Yik}), \hspace*{0.5 cm} K= 1,.....m_{i}\\
	X_{ij}|\mu_{Xij},\sigma_{Xij}\stackrel{ind}{\sim} \prod_{j=1}^{p}N(\mu_{ij},\sigma_{Xij}),\hspace*{0.5 cm} j= 1,.....n_{i}\\
	\Delta_{i} = E_{G_{Yi}}(G_{X_{i}}(Y_{ik})) = p(X_{ij}\textless Y_{ik})\label{80}
	\end{split}
	\end{align}
	\begin{align}
	\begin{split}
	\theta_{X_{ij}} = (\mu X_{ij},\sigma X_{ij})^{E} \hspace*{0.3cm}\text{and} \hspace*{0.3cm}\theta_{Y_{ik}} = (\mu Y_{ik},\sigma Y_{ik})^{E}\\
	\theta_{X_{ij}}|G_{X_{i}} \sim G_{X_{i}} \hspace*{0.3cm}\text{and} \hspace*{0.3cm} \theta_{Y_{ik}}|G_{Y_{i}} \sim G_{Y_{i}}\\
	(G_{X_{i}},G_{Y_{i}}) \sim nDP(\alpha,\gamma,G^{*}_{0})\\
	\alpha \sim Gam(a_{\alpha},b_{\alpha}), \hspace*{0.3cm} \gamma \sim Gam(a_{\gamma},b_{\gamma})\\
	G^{*}_{0} \sim N-IG(\mu_{0},k_{0},a_{0},d_{0})\\\label{90}
	%(\beta,\sigma_{E}) \sim N-IG(\mu_{1},k_{1},a_{1},d_{1}) 
	\end{split}
	\end{align}
	Where, the fixed hyperparameters  are $\mu_{0}$,$k_{0}$,$a_{0}$,$d_{0}$.
	%$\mu_{1}$,$k_{1}$,$a_{1}$,$d_{1}$.
	
\end{block}

\begin{block}{\textbf {Posteriror Profile}}
	
	The biological marker posterior profile is;
	\begin{eqnarray}
	\Delta^{*}_{i}= E_{G^{*}_{Yi}} (G^{*}_{Xi}(Y_{ik})) = \int{G^{*}_{Xi}}(y)dG^{*}_{Yi}(y)dy.\label{22}
	\end{eqnarray}
	Where $G^{*} _{Xi}$ = $\sum_{l=1}^{\infty}$ $w^{*}_{l}$$\sigma_{\theta^{*}_{l}}$ and 
	$G^{*} _{Yi}$ = $\sum_{l'=1}^{\infty}$ $w^{*}_{l'}$$\sigma_{\theta^{*}_{l'}}$, thus, the estimate of the  posterior biological marker profile is the mean  divided by the posterior values which is ;
	\begin{eqnarray}
	\Delta^{*}_{i} = \sum_{l}\sum_{l'}w^{*}_{l}w^{*}_{l'}\left(1-\Phi\left(\frac{\mu^{*}_{l}-\mu^{*}_{l'}}{\sqrt{\sigma^{2*}_{l}} +\sigma^{2*}_{l'}}\right)\right).\label{23}
	\end{eqnarray}
\end{block}
\begin{block}{\textbf {Sampling Algorithm}}
	Markov Chain Monte Carlo (MCMC) algorithm for posterior inference is used. The full conditional to update the nDP are obtained as  described by \cite{rodriguez2008nested}, which are based on a truncated dirichlet process. The parameters of the baseline distribution $G^{*}_{0}$ are updated at each iteration using all the samples represented by the biomarker levels (X,Y).The algorithm is developed using a truncation of a Dirichlet process to give approximate truncation to the stick breaking process of a Dirichlet process leading to method of computation in finite mixture models. This assumes that individuals are clustered into K groups and for every individual the observations on the biomarker level can be clustered into L groups.
\end{block}

\end{column}
\begin{column}{.3\linewidth} % Set the width of this column

\begin{block}{\textbf {Simulation}}
	$N$ samples are obtained from a mixture of four  Gaussian distributions.\\The mixture distribution is;
	\begin{eqnarray}
	f(x) = \sum_{i}w_{i}N(\mu_{i},\sigma_{i}^{2})
	\end{eqnarray}
	The study generates $J=40$ samples, for $j=1,...,40$, each of size $100$. Every sample is generated  from a mixture of $k=4$ Gaussian mixtures summarized in Table \ref{table 1}.
	\begin{table}[!htb]
		\begin{center}
			\caption{The Components of Various Gaussian Distributions. }
			\label{table 1}
			\setlength{\tabcolsep}{2pt}
			\small
			\begin{tabular}{|l|lll|lll|lll|lll|}
				\hline
				Distribution & \multicolumn{3}{l|}{Component 1} & \multicolumn{3}{l|}{Component 2} & \multicolumn{3}{l|}{Component 3} & \multicolumn{3}{l|}{Component 4} \\ 
				& w      & $\mu$   & $\sigma^2$   & w      & $\mu$   & $\sigma^2$   & w      & $\mu$   & $\sigma^2$   & w      & $\mu$   & $\sigma^2$   \\ \hline
				S1           & 0.85   & 0       & 1            & 0.15   & 4       & 3            & -      & -       & -            & -      & -       & -            \\ \hline
				S2           & 0.65   & 0       & 1            & 0.35   & 4    & 3            & -      & -       & -            & -      & -       & -            \\ \hline
				S3           & 0.4    & 0       & 1            & 0.3   & -2      & 3            & 0.3   & 3    & 3         & -      & -       & -            \\ \hline
				S4           & 0.39   & 0       & 1            & 0.29   & -2      & 3            & 0.29   & 3       & 3            & 0.03   & 11    & 3  \\ \hline       
			\end{tabular}
		\end{center}
	\end{table}
\end{block}

\begin{block}{\textbf {Posterior Simulation}}
	To obtain the posterior simulation, then, the  precision parameters $\alpha$ and $\gamma$ are both fixed to $1$ and the Normal-Inverse Gamma distribution which is the baseline measure (base distribution) has parameters; $\mu_{0} = 0$, $k_{0} =0.01$, $a_0=3$, and $d_0 =1$, such that; NIG(0,0.01,3,1).\\
	The study runs MCMC chains with  12000 iterations, discarding the first 2000 iterations. 
		\begin{figure}[!htb]
			\center{\includegraphics[width=\textwidth]
				{estimate1}}
			\caption{\label{fig:True distribution} Representation of the estimated distribution }
			\label{figure: 11}
		\end{figure}	
	
		\begin{figure}[!htb]
			\centering
			{\includegraphics[width=\textwidth]
				{cluster2}}
			\caption{\label{fig:True distribution} Representation of the posterior co-clustering probabilities for all the distributions}
			\label{figure: 190}
		\end{figure}
		\begin{figure}[!htb]
			\centering
			{\includegraphics[width=\textwidth]
				{dendrogram}}
			\caption{\label{fig:True distribution} Dendrogram for hierarchical clustering}
			\label{figure: 195}
		\end{figure}
\end{block}
\begin{block}{\textbf {Conclusion}}
	In the simulation study the Bayesian non-parametric mixture model showed a good performance in differentiating the unimodal distributions from the multimodal distributions. Also, the model was able to cluster observations into different clusters. Additionally, the developed model in this study revealed that Bayesian non-parametric mixture model can be used to obtain flexible estimates of the individual biomarkers and characterize the heterogeneity of how  subjects  respond to treatment. The model also performed better in clustering distributions.  
\end{block}

\begin{block}{\textbf {References}}
	\bibliographystyle{newapa}
	
	\small \bibliography{referencestyle}
	
	
\end{block}
\end{column}
\end{columns}
\end{frame}
\end{document}

